Meperidine 100mg/ml MDV, 5ml 90 day expiration,
Nora Apothecary and Alternative Therapies
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
💊 Drugs • 3,313 recalls
Nora Apothecary and Alternative Therapies
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
Nora Apothecary and Alternative Therapies
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
Nora Apothecary and Alternative Therapies
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
Nora Apothecary and Alternative Therapies
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
Nora Apothecary and Alternative Therapies
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
Nora Apothecary and Alternative Therapies
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
Nora Apothecary and Alternative Therapies
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
Nora Apothecary and Alternative Therapies
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
Nora Apothecary and Alternative Therapies
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
Nora Apothecary and Alternative Therapies
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
Nora Apothecary and Alternative Therapies
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
Novartis Consumer Health
Labeling: Incorrect or Missing Lot and/or Expiration date; The Lot and/or Expiration date on the tube may not be legible in this lot.
Marketed Without an Approved NDA/ANDA: product may contain undeclared sildenafil, tadalafil and analogues of these FDA approved active ingredients, making them unapproved drugs
Non-Sterility: Green Valley Drugs received positive sterility results from their testing lab on two lots of Methylprednisolone Preservative Free 40 mg/mL injectable suspension and one lot of Cyanocobalamin 1000 mcg/mL injection, 30 mL MDV.
CGMP Deviations: this product is being recalled because an FDA inspection revealed that it was not manufactured under current good manufacturing practices.
Labeling: Not Elsewhere Classified: Pentrexcilina Tablets and Pentrexcilina Liquid are being recalled because the product labels are misleading because they may be confused with Pentrexyl, a prescription antibiotic used to treat respiratory illnesses in Mexico.
Brower Enterprises
Marketed without an Approved NDA/ANDA: Brower Enterprises Inc., is recalling its WOW Health Enterprises Dietary Supplement, because it contains undeclared drug ingredients making it an unapproved drug. FDA sample analysis has found the product to contain methocarbamol, dexamethasone, and diclofenac.
Marketed without an Approved NDA/ANDA; product found to contain sulfoaildenafil, an analogue of sildenafil, the active ingredient in a FDA approved product used for erectile dysfunction, making it an unapproved new drug
Labeling: Not Elsewhere Classified: This product is misbranded because the product is not sterile and the labeling is misleading in relation to sterility claims.
Labeling: Not Elsewhere Classified: This product is misbranded because the product is not sterile and the labeling is misleading in relation to sterility claims.